RA Capital Management has launched its fourth special purpose acquisition company, extending a strategy that reflects the firm's growing presence in private health care investing. The firm has invested more than $5 billion in private companies since 2020 and backed hundreds of biotech and health care businesses, many of which have gone public or been acquired.
Continue Reading
Sign up for FREE to read the full article and access 148K+ alternative investment headlines.